Stroke Journal

FEBRUARY 1, 2024

Introduction:There are significant and longstanding inequities in stroke prevalence and care as well as outcomes. Social determinants of health (SDOH) are known to be a risk factor in post-stroke recovery. SDOH also put individuals at higher risk for 90-day mortality. 12.5%, and 90-day readmissions ranging from 18.9%

Stroke 40

Stroke Strokes Quality of Life CMS 40

Stroke Journal

FEBRUARY 1, 2024

Introduction:There are significant and longstanding inequities in stroke prevalence and care as well as outcomes. Social determinants of health (SDOH) are known to be a risk factor in post-stroke recovery. SDOH also put individuals at higher risk for 90-day mortality. 12.5%, and 90-day readmissions ranging from 18.9%

Stroke 40

Stroke Strokes Quality of Life CMS 40

CardiacWire

JANUARY 17, 2024

Practices with Ambulatory Surgery Centers (ASCs) are becoming particularly attractive, as CMS added 23 ASC cardiac catheterization and PCI codes in just the last two years. Previous studies have shown that PE ownership hurts care quality and outcomes.

CMS 52

CMS Outpatient Hospital Outcomes 52

Stroke Journal

JANUARY 30, 2025

Conclusion:Cluster analyses can elucidate high-risk patient profiles and guide in identifying intervenable targets and prioritizing provision of appropriate care, including rehabilitation, to optimize long-term patient outcomes. Post acute care at an inpatient rehabilitation facility minimized the risk of low HT (vs. vs. 28.5%) (Fig.

Inpatient 40

Inpatient Stroke Strokes CMS 40

GEMMS

MARCH 7, 2024

In late 2023, CMS released the 2024 Medicare Physician Fee Schedule (MPFS) Final Rule, ushering in key policy changes for the Quality Payment Program (QPP). Report 6 measures, including one Outcome or other High Priority measure for 12 months on at least 70% of eligible encounters to receive a score based on 2023 National Benchmarks.

Medicare 52

Medicare CMS Document Technology 52

Society of Thoracic Surgeons - Technology

OCTOBER 21, 2021

Removing these barriers would allow surgeons, physicians, hospitals, health systems, and others to conduct longitudinal analyses and gain new insights into long-term outcomes for patients undergoing procedures such as coronary artery bypass grafting (CABG)—the most common operation performed by cardiac surgeons.

Technology 40

Technology Coronary Artery Bypass Graft Cardiothoracic Aortic valve 40

GEMMS

SEPTEMBER 12, 2023

These features are pivotal in ensuring accurate diagnoses, streamlined workflows, and improved patient outcomes. Regulation-Ready with AUC Integration GEMMS One simplifies compliance by seamlessly incorporating the Complex Appropriate Use Criteria (AUC) mandated by CMS.

Echocardiogram 52

Echocardiogram Reimbursement Patient Care Article 52

DAIC

MARCH 13, 2024

CMS has reviewed the CardiAMP Heart Failure II Trial and approved the investigational product, related and routine items and services for purposes of Medicare coverage. CMS has reviewed the CardiAMP Heart Failure II Trial and approved the investigational product, related and routine items and services for purposes of Medicare coverage.

CMS 111

CMS Heart Failure Reimbursement Quality of Life 111

GEMMS

JANUARY 2, 2024

Key features include: Compliance Under Appropriate Use Criteria (AUC) – GEMMS ONE meets CMS standards and requirements by including an AUC orders module, part of its integrated system. This enables early intervention, minimizes hospital admissions, and helps improve patient outcomes.

Document 52

Document Patient Care Private Practice Reimbursement 52

DAIC

MARCH 28, 2025

This innovative technology maximizes operational efficiency, enhances staff expertise, and delivers better patient outcomes, making it a wise long-term investment. a huge win: CMS significantly increases Medicare payments for cardiac CT. For more information on Revolution Vibe, please visit gehealthcare.com. 2012) 380:2095128.

Technology 59

Technology Coronary Artery Disease Atrial Fibrillation Medicare 59

DAIC

DECEMBER 8, 2023

a medical device company dedicated to improving outcomes for patients with cardiac and renal impairment, announced the enrollment of the first patients in the company's IDE pivotal trial. These patients have very poor outcomes in terms of death and rehospitalization and therefore new therapy options are critically needed," stated Dr. Chehab.

Technology 113

Technology Heart Failure Heart Transplant Transplant 113

DAIC

JULY 25, 2024

The CardiAMP clinical development for heart failure is supported by the Maryland Stem Cell Research Fund and is reimbursed by Center for Medicare and Medicaid Services (CMS) for both treatment and control procedures. CAUTION - Limited by United States law to investigational use.

Heart Failure 111

Heart Failure Quality of Life CMS Reimbursement 111

DAIC

MARCH 7, 2024

Despite improvements with current medications and devices, heart failure remains at epidemic proportions and we now have an exciting opportunity for a therapy to improve important, objective outcomes, such as mortality and hospital re-admissions rates. “We The CardiAMP HF II trial is expected to similarly secure CMS reimbursement.

Heart Failure 105

Heart Failure Biomarkers Reimbursement CMS 105

Stroke Journal

JANUARY 30, 2025

The epidemiology of AIS and concomitant CM subtypes is not well-described.Methods:Adult hospitalizations in the National Inpatient Sample (NIS) from 2018-2020 with diagnosis of AIS and concomitant CM were characterized by CM etiologies using International Classification of Diseases-10 codes.

Hospital 40

Hospital Outcomes Stroke Strokes 40

Stroke Journal

JANUARY 30, 2025

The Alzheimers Associations expert guidance is to avoid co-prescribing; however, CMS and FDA do not restrict or warn against it. Monthly model outcomes included ICH, ischemic stroke, cognitive impairment, quality-adjusted life months (QALMs), and survival. The model was populated with the Health and Retirement Study-AF cohort.

Quality of Life 40

Quality of Life CMS Atrial Fibrillation Stroke 40

Stroke Journal

JANUARY 30, 2025

We longitudinally followed the patients by linking the registry data to the Center for Medicare&Medicaid Service (CMS) claims data.

Medicare 40

Medicare CMS Medicaid Myocardial Infarction 40

Stroke Journal

JANUARY 30, 2025

Clinical data extracted from an EMR-driven registry were linked to PAC utilization information retrieved from a CMS Qualified Entity with 80% data for the Texas state population (including 100% of Medicare Fee-for-Service). Factors associated with 1-YR outcomes were evaluated via multivariate logistic regression. female; 63.6%

Stroke 40

Stroke Strokes Medicare CMS 40

Stroke Journal

FEBRUARY 1, 2024

Methods:Data were retrieved from a CMS Qualified Entity housing healthcare utilization data for ≥80% of the Texas state population (100% of Medicare Fee-for-Service). Conclusion:Post stroke transitions of care patterns may yield insights as to the long-term trajectory of outcomes. and 82.3% (Panel D).Conclusion:Post

Medicare 40

Medicare Hemorrhage Inpatient Nursing 40

DAIC

JANUARY 13, 2025

Additionally, the company announced that the Centers for Medicare & Medicaid Services (CMS) has granted Category B approval for the investigational device exemption (IDE) study, ensuring Medicare coverage for the device, related and routine items, and services for the ELITE-BTK trial. Secemsky, M.D.,

Peripheral Arterial Disease 52

Peripheral Arterial Disease CMS Medicare Medicaid 52

Cardiometabolic Health Congress

DECEMBER 9, 2024

Without this information, it’s nearly impossible for patients to make informed choices about managing their condition, leading to poor long-term outcomes. As insurance coverage improves , especially through programs like CMS, more patients can access this life-changing technology.

Diabetes 52

Diabetes Technology Education CMS 52

Dr. Smith's ECG Blog

APRIL 9, 2025

cms) with moderately reduced systolic function. But it does show a strong association of better outcome with lidocaine vs. amiodarone. Our objective was to use 'target trial emulation' methodology to compare the outcomes of patients who received amiodarone or lidocaine during resuscitation. Smida T et al.

Defibrillator 63

Defibrillator Cardiac Arrest Myocardial Infarction STEMI 63

DAIC

JANUARY 27, 2025

13, 2025 Medtronic recentlyannounced that the Centers for Medicare & Medicaid Services (CMS) is opening a national coverage analysis (NCA) on renal denervation, a process that will allow the agency to review and develop a national Medicare coverage policy for renal denervation procedures for patients with hypertension. Available at: [link].

CMS 52

CMS Blood Pressure Medicare Hypertension 52

The Beat Blog

AUGUST 12, 2022

They matter because their member bases are growing fast, and they’re driving both better outcomes and lower costs. And their newest program, called ACO Reach, has attracted hundreds of applicants, as CMS seeks to ensure historically underserved patients are fully included.

Medicare 52

Medicare Nursing Health Disparities Cardiovascular Disease 52